NCT01899404View on ClinicalTrials.gov

MRI FDG PET Imaging Cervix

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 3, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Cervical Cancer Squamous Cell
Interventions
BIOLOGICAL

18-FDG PET/CT, DWI, DCE-MRI

All patients on this study will receive a Diffuse Weighted MRI and Dynamic Contrast Enhancing MRI during the routine MRI session on the day of brachytherapy (additional 10 minutes), and a FDG PET/CT scanning session on the day of brachytherapy.

Trial Locations (1)

M5G 2M9

University Health Network, The Princess Margaret, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT01899404 - MRI FDG PET Imaging Cervix | Biotech Hunter | Biotech Hunter